Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/ neu-positive tumour cells.

Saved in:
Bibliographic Details
Title: Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/ neu-positive tumour cells.
Authors: Karagiannis, Panagiotis1, Singer, Josef2, Hunt, James3, Gan, Samuel K. E.3, Rudman, Sarah M.4, Mechtcheriakova, Diana2, Knittelfelder, Regina2, Daniels, Tracy R.5, Hobson, Philip S.3, Beavil, Andrew J.3, Spicer, James4, Nestle, Frank O.1, Penichet, Manuel L.5,6,7, Gould, Hannah J.3, Jensen-Jarolim, Erika2, Karagiannis, Sophia N.1,2 sophia.karagiannis@kcl.ac.uk
Source: Cancer Immunology, Immunotherapy. Jun2009, Vol. 58 Issue 6, p915-930. 16p. 1 Diagram, 4 Charts, 5 Graphs.
Database: Academic Search Ultimate
Description
ISSN:03407004
DOI:10.1007/s00262-008-0607-1